RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,541,073 | +51.3% | 6,982,475 | +80.7% | 0.00% | – |
| Q2 2023 | $4,984,974 | +655.6% | 3,864,321 | +673.2% | 0.00% | – |
| Q1 2023 | $659,753 | -27.3% | 499,813 | -17.4% | 0.00% | – |
| Q4 2022 | $907,390 | -14.7% | 604,925 | -33.0% | 0.00% | – |
| Q3 2022 | $1,064,000 | -57.0% | 902,570 | -58.8% | 0.00% | – |
| Q2 2022 | $2,474,000 | -27.2% | 2,188,978 | +92.6% | 0.00% | – |
| Q1 2022 | $3,399,000 | +47.7% | 1,136,500 | +30.9% | 0.00% | – |
| Q4 2021 | $2,301,000 | -40.4% | 867,909 | -18.4% | 0.00% | -100.0% |
| Q3 2021 | $3,859,000 | -36.6% | 1,063,036 | -24.3% | 0.00% | 0.0% |
| Q2 2021 | $6,091,000 | +28.8% | 1,403,515 | +1.5% | 0.00% | 0.0% |
| Q1 2021 | $4,729,000 | -74.1% | 1,382,579 | -73.5% | 0.00% | -66.7% |
| Q4 2020 | $18,288,000 | +163.1% | 5,225,303 | +80.4% | 0.00% | +200.0% |
| Q3 2020 | $6,950,000 | +178.8% | 2,895,713 | +112.5% | 0.00% | 0.0% |
| Q2 2020 | $2,493,000 | -36.4% | 1,362,531 | -45.8% | 0.00% | 0.0% |
| Q1 2020 | $3,918,000 | +65.5% | 2,511,579 | +127.1% | 0.00% | 0.0% |
| Q4 2019 | $2,368,000 | +1437.7% | 1,106,044 | +1245.7% | 0.00% | – |
| Q3 2019 | $154,000 | -55.2% | 82,189 | -37.8% | 0.00% | – |
| Q2 2019 | $344,000 | -92.9% | 132,080 | -93.0% | 0.00% | -100.0% |
| Q1 2019 | $4,835,000 | -25.5% | 1,881,093 | -33.4% | 0.00% | -50.0% |
| Q4 2018 | $6,492,000 | -25.4% | 2,822,724 | +4.2% | 0.00% | 0.0% |
| Q3 2018 | $8,699,000 | +112.1% | 2,710,087 | +87.0% | 0.00% | +100.0% |
| Q2 2018 | $4,102,000 | +65.2% | 1,449,369 | +106.6% | 0.00% | 0.0% |
| Q1 2018 | $2,483,000 | +106.6% | 701,435 | +126.4% | 0.00% | – |
| Q4 2017 | $1,202,000 | +163.6% | 309,827 | +72.7% | 0.00% | – |
| Q3 2017 | $456,000 | -19.0% | 179,384 | -13.2% | 0.00% | – |
| Q2 2017 | $563,000 | -71.7% | 206,560 | -65.6% | 0.00% | – |
| Q1 2017 | $1,988,000 | -39.5% | 600,978 | -56.5% | 0.00% | -100.0% |
| Q4 2016 | $3,284,000 | +1714.4% | 1,380,054 | +2703.2% | 0.00% | – |
| Q3 2016 | $181,000 | +48.4% | 49,232 | -10.1% | 0.00% | – |
| Q2 2016 | $122,000 | -47.9% | 54,778 | -51.2% | 0.00% | – |
| Q1 2016 | $234,000 | -66.1% | 112,222 | -50.7% | 0.00% | – |
| Q4 2015 | $690,000 | +100.6% | 227,679 | +63.3% | 0.00% | – |
| Q3 2015 | $344,000 | -40.0% | 139,398 | -21.9% | 0.00% | – |
| Q2 2015 | $573,000 | +99.0% | 178,550 | +121.2% | 0.00% | – |
| Q1 2015 | $288,000 | +4.7% | 80,721 | -33.3% | 0.00% | – |
| Q4 2014 | $275,000 | -12.1% | 120,937 | -25.2% | 0.00% | – |
| Q3 2014 | $313,000 | -94.1% | 161,704 | -89.0% | 0.00% | -100.0% |
| Q2 2014 | $5,340,000 | -9.2% | 1,471,180 | -2.9% | 0.00% | 0.0% |
| Q1 2014 | $5,878,000 | +30.2% | 1,515,010 | -4.4% | 0.00% | 0.0% |
| Q4 2013 | $4,514,000 | -8.6% | 1,584,124 | +14.8% | 0.00% | 0.0% |
| Q3 2013 | $4,941,000 | +4087.3% | 1,380,191 | +3788.4% | 0.00% | – |
| Q2 2013 | $118,000 | – | 35,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |